The Innovative Medicines Initiative (IMI) has just launched a new programme worth €223.7 million aimed at tackling antibiotic resistance and speeding up the delivery of new antibiotics to patients. This is no small challenge given that in Europe in...
Identification
Bonjour, l'accès à cet article est réservé aux abonnés. Veuillez vous identifier dans le cadre ci-dessous.
Commission to introduce mandatory accessibility features - 04/12/2012
Dalli affair: MEPs call for explanation - 04/12/2012
Commission to introduce mandatory accessibility features - 
